Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-27

Clinical Trial Update: Optimization Post-TAVR to IMprove Activity Levels (OPTIMAL Study) [NA]

View source ↗

Summary

The OPTIMAL study, sponsored by Johns Hopkins University, reports on optimizing recovery after transcatheter aortic valve replacement to improve activity levels…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Aortic Valve Disease, Aortic Valve Replacement | NA | Status: COMPLETED